The mTORIs emerged as a promising new medical treatment option for vascular anomalies, particularly for vascular malformations. Refractory or in progression lesions are subject to additional benefit. mTORIs should be considered part of the armamentarium in the management of these conditions. Further studies are needed to better determine is effects and to compare sirolimus to newer mTORI. 
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INTRODUCTION:
Research is an integral part of plastic surgery residency training and practice, and provides a foundation for knowledge advancement in our field. Furthermore, it improves patient care by facilitating the delivery of evidence-based therapies. As research is dynamic, and is often contingent on funding sources, it is important to continuously assess output. To our knowledge, this is the first study to describe Canadian plastic surgery research trends.
MATERIALS AND METHODS:
Data was obtained from the Scopus Database and articles published in the top general and specialty plastic surgery journals were included. All articles written in English and related to document-types 'articles', 'reviews', and 'letters' published over a 10-year period (2006-2015) were tracked. Articles were then individually analyzed, and only those who had a first and/or corresponding author with an appointment at a Canadian institution were included in the final analysis. CONCLUSION: Canada continues to be a leading contributor of high impact research in plastic and reconstructive surgery. This study provides novel insight into a number of pertinent trends, which may be used to determine funding patterns, understudied domains of plastic surgery, domains most likely to be funded, and changes in publication practices.
RESULTS:
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The Classification and Prognosis of Periocular Complications Following Cosmetic Filler Injection
Yong Hyun Kim, MD; Chang Sik Pak, MD
INTRODUCTION:
Common side effects during hyaluronic acid filler injections are typically mild and reversible, but several reports of blindness have received attention.
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The present study focused on orbital symptoms combined with blindness, aiming to classify affected patients and predict their disease course and prognosis.
METHODS:
From September 2012 to August 2015, 9 patients with vision loss after filler injection were retrospectively reviewed. Ptosis, ophthalmoplegia, and enophthalmos were recorded over 6-month follow-up, and patients were classified into 4 types according to periocular symptom manifestation. Additionally, 2 cadaveric eyeballs were anatomically studied to investigate anatomical evidence for the mechanism of enophthalmos development.
RESULTS:
Two patients were categorized as Type I (blindness without ptosis or ophthalmoplegia), two patients as Type II (blindness and ptosis without ophthalmoplegia), two patients as Type III (blindness and ophthalmoplegia without ptosis), and three patients as Type IV (blindness with ptosis and ophthalmoplegia). During the follow-up periods, there was no recovery from blindness, but ptosis and ophthalmoplegia fully recovered except in one Type IV patient with mild strabismus. At 6 months after filler injection, an average of 1-mm enophthalmos developed in Type II and III patients, and 1.7-mm enophthalmos in Type IV patients. Anatomical investigation revealed previously undiscovered branching to periorbital adipose tissue from ophthalmic arteries.
CONCLUSION:
The present study includes previously unpublished information about orbital symptom manifestations and prognosis combined with blindness due to retinal artery occlusion after cosmetic filler injection. Information about symptom progression and prediction of injury will help clinicians when managing such devastating complications.
